Therefore, it is likely that when fibrosis/cirrhosis progresses to HCC, it may ‘carry forward’ its downregulated hepcidin expression to the next stage of HCC, and this may contribute to the observed downregulation of hepcidin in HCC. The gene discussed is HAMP; the disease is hepatocellular carcinoma.